Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Norcross, GA
SEC filing record 1 source field available
Fiscal year end
31 December
GALECTIN THERAPEUTICS INC has filed 1,569 SEC EDGAR filings since 13 Jun 2001

SEC filing history

Showing 801-825 of 1,000 matching filings.

Per page
25
Current page
33
4

PRIMARY DOCUMENT

Filing date
15 Aug 2014
Reporting date
14 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Aug 2014
Reporting date
14 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Aug 2014
Reporting date
13 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-198070

S-8

Filing date
12 Aug 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
07 Aug 2014
Reporting date
07 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

FORM 8-K

Filing date
05 Aug 2014
Reporting date
05 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
29 Jul 2014
Reporting date
29 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
22 Jul 2014
Reporting date
22 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
28 May 2014
Reporting date
28 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
20 May 2014
Reporting date
14 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
16 May 2014
Reporting date
14 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 May 2014
Reporting date
13 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

FORM 8-K

Filing date
14 May 2014
Reporting date
14 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
13 May 2014
Reporting date
13 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
08 May 2014
Reporting date
08 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
23 Apr 2014
Reporting date
23 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Apr 2014
Reporting date
16 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Apr 2014
Reporting date
11 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-194747

EFFECT filing

Filing date
31 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

FORM 8-K

Filing date
31 Mar 2014
Reporting date
31 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31791

8-K

Filing date
25 Mar 2014
Reporting date
25 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-194747

S-3

Filing date
21 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-31791

DEF 14A

Filing date
21 Mar 2014
Reporting date
14 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .